AKR1B10 抗体 (AA 76-143)
Quick Overview for AKR1B10 抗体 (AA 76-143) (ABIN566073)
抗原
See all AKR1B10 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 76-143
-
原理
- Mouse polyclonal antibody raised against a partial recombinant AKR1B10.
-
序列
- VSKLWPTFFE RPLVRKAFEK TLKDLKLSYL DVYLIHWPQG FKSGDDLFPK DDKGNAIGGK ATFLDAWE
-
交叉反应
- 人, 小鼠
-
产品特性
- Antibody Reactive Against Recombinant Protein.
-
免疫原
- AKR1B10 (NP_064695, 76 a.a. ~ 143 a.a) partial recombinant protein with GST tag.
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- 50 % glycerol
-
注意事项
- Aliquot to avoid repeated freezing and thawing.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma." in: Journal of hepatology, Vol. 59, Issue 3, pp. 510-7, (2013) (PubMed).
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib." in: Molecular cancer therapeutics, Vol. 8, Issue 7, pp. 1995-2006, (2009) (PubMed).
: "
-
SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma." in: Journal of hepatology, Vol. 59, Issue 3, pp. 510-7, (2013) (PubMed).
-
- AKR1B10 (Aldo-Keto Reductase Family 1, Member B10 (Aldose Reductase) (AKR1B10))
-
别名
- AKR1B10
-
背景
-
Full Gene Name: aldo-keto reductase family 1, member B10 (aldose reductase)
Synonyms: AKR1B11,AKR1B12,ALDRLn,ARL-1,ARL1,HIS,HSI,MGC14103 -
基因ID
- 57016
-
NCBI登录号
- NM_020299
抗原
-